Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate

Antibody–drug conjugates (ADCs) are a potential and promising therapy for a wide variety of cancers, including breast cancer. ADC-based drugs represent a rapidly growing field of breast cancer therapy. Various ADC drug therapies have progressed over the past decade and have generated diverse opportu...

Descripción completa

Detalles Bibliográficos
Autores principales: Subhan, Md Abdus, Torchilin, Vladimir P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144345/
https://www.ncbi.nlm.nih.gov/pubmed/37111727
http://dx.doi.org/10.3390/pharmaceutics15041242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144345/
https://www.ncbi.nlm.nih.gov/pubmed/37111727
http://dx.doi.org/10.3390/pharmaceutics15041242

Ejemplares similares